Dystrogen Therapeutics is Drug Discovery in United States that focus on neurodegenerative disorders business. Founded in 2017. They cover business area such as developer, novel chimeric cell therapy, patient, Sarcopenia, rare disease, Duchenne muscular dystrophy, sickle cell anemia, neurodegenerative disorder, their disease.
2017
( 7 years old in 2024 )
Neurodegenerative Disorders
-
1415 West 37th Street
Chicago, IL 60609
United States
Private
developernovel chimeric cell therapypatientSarcopeniarare diseaseDuchenne muscular dystrophysickle cell anemianeurodegenerative disordertheir disease
* We use standard office opening hours in near Dystrogen Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Dystrogen Therapeutics is Drug Discovery business from United States that founded in 2017 (7 years old in 2024), Dystrogen Therapeutics business is focusing on Neurodegenerative Disorders.
Dystrogen Therapeutics headquarter office and corporate office address is located in 1415 West 37th Street Chicago, IL 60609 United States.
Dystrogen Therapeutics was founded in United States.
In 2024, Dystrogen Therapeutics is currently focus on neurodegenerative disorders sector.
Above is snippet of Google Trends for "neurodegenerative disorders" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Dystrogen Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
